✦ LIBER ✦

Predicting the outcome of patients with higher-risk myelodysplastic syndrome treated with hypomethylating agents

✍ Scribed by Itzykson, Raphael; Fenaux, Pierre

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of higher risk myelodysplastic

✍ Mahesh Seetharam; Alice C. Fan; Mai Tran; Liwen Xu; John P. Renschler; Dean W. F 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 395 KB

PCN115 Patterns of Care in Patients With

✍ Faria, C.; Chang, E.; Powers, A.; Cherepanov, D.; Broder, M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Does addition of erythropoiesis stimulat

✍ R. Itzykson; S. Thépot; O. Beyne-Rauzy; S. Ame; F. Isnard; F. Dreyfus; C. Salano 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 204 KB

Hematologic Outcomes of Myelodysplastic

✍ Rodolfo E. Bordoni; Bruce A. Feinberg; James W. Gilmore; Sally Haislip; James H. 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 235 KB

Practical Recommendations for Hypomethyl

✍ Steensma, David P.; Stone, Richard M. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Feasibility of hypomethylating agents fo

✍ Kim, D-Y; Lee, J-H; Park, Y-H; Lee, J-H; Kim, S-D; Choi, Y; Lee, S-B; Lee, K-H; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 318 KB